Glycosylation differences of an anti-VEGF monoclonal antibody (PRO-169) and its extensive comparison with Bevacizumab
出版年份 2023 全文链接
标题
Glycosylation differences of an anti-VEGF monoclonal antibody (PRO-169) and its extensive comparison with Bevacizumab
作者
关键词
-
出版物
BIOLOGICALS
Volume 84, Issue -, Pages 101711
出版商
Elsevier BV
发表日期
2023-09-23
DOI
10.1016/j.biologicals.2023.101711
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Structural and Functional Analysis of CEX Fractions Collected from a Novel Avastin® Biosimilar Candidate and Its Innovator: A Comparative Study
- (2022) Busra Gurel et al. Pharmaceutics
- LC–MS based case-by-case analysis of the impact of acidic and basic charge variants of bevacizumab on stability and biological activity
- (2021) Sumit Kumar Singh et al. Scientific Reports
- Oxidation and Deamidation of Monoclonal Antibody Products: Potential Impact on Stability, Biological Activity, and Efficacy
- (2021) Surbhi Gupta et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Efficacy & Safety of Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Non-small Cell Lung Cancer(MAPLE):A Randomized,Double-blind,Phase 3 Study
- (2019) Nicholas Thatcher et al. CLINICAL CANCER RESEARCH
- Comparing The Efficacy Of An Anti-Human VEGF-A Neutralizing Antibody Versus Bevacizumab On A Laser-Induced Choroidal Neovascularization (CNV) Rhesus Monkey Model
- (2019) Oscar Olvera-Montaño et al. Drug Design Development and Therapy
- Supplementing glycosylation: A review of applying nucleotide-sugar precursors to growth medium to affect therapeutic recombinant protein glycoform distributions
- (2018) Eric J.M. Blondeel et al. BIOTECHNOLOGY ADVANCES
- The Impact of Prefilled Syringes on Endophthalmitis following Intravitreal Injection of Ranibizumab
- (2018) Philip P. Storey et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Biosimilarity assessment of biosimilar therapeutic monoclonal antibodies
- (2018) Akiko Ishii-Watabe et al. Drug Metabolism and Pharmacokinetics
- Glyco-Engineering of Human IgG-Fc to Modulate Biologic Activities
- (2016) Roy Jefferis CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Antidrug Antibody Formation in Oncology: Clinical Relevance and Challenges
- (2016) Emilie M.J. van Brummelen et al. ONCOLOGIST
- Ranibizumab Prefilled Syringes: Benefits of Reduced Syringe Preparation Times and Less Complex Preparation Procedures
- (2015) Eric Souied et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- Antibody Glycosylation and Its Impact on the Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies and Fc-Fusion Proteins
- (2015) Liming Liu JOURNAL OF PHARMACEUTICAL SCIENCES
- Recommendations for the development and validation of confirmatory anti-drug antibody assays
- (2015) Darshana Jani et al. Bioanalysis
- Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants
- (2015) Tetyana Dashivets et al. PLoS One
- Influence of glycosylation pattern on the molecular properties of monoclonal antibodies
- (2014) Kai Zheng et al. mAbs
- Statistical methods and tool for cut point analysis in immunogenicity assays
- (2013) Lanju Zhang et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial
- (2013) Usha Chakravarthy et al. LANCET
- A Brief History of Anti-VEGF for the Treatment of Ocular Angiogenesis
- (2012) Leo A. Kim et al. AMERICAN JOURNAL OF PATHOLOGY
- Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
- (2012) Daniel F. Martin et al. OPHTHALMOLOGY
- Glycosylation profiles of therapeutic antibody pharmaceuticals
- (2011) Christoph Wacker et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans
- (2011) A. M. Goetze et al. GLYCOBIOLOGY
- Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Influence of Non-Toxic Doses of Bevacizumab and Ranibizumab on Endothelial Functions and Inhibition of Angiogenesis
- (2010) Aya Barzelay et al. CURRENT EYE RESEARCH
- Charge variants in IgG1
- (2010) Leslie A. Khawli et al. mAbs
- Investigation of the role of neutralizing antibodies against bevacizumab as mediators of tachyphylaxis
- (2009) Farzin Forooghian et al. ACTA OPHTHALMOLOGICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started